A Digital Revolution in the Pharmaceutical Industry
White Paper May 06, 2020
In a world where we strive to get life-transforming treatments into the hands of patients as quickly as possible, embracing digital transformation is essential. However, to be successful in this new digital era, it is key that pharmaceutical companies have an interoperable digital strategy to support themselves through research and development, regulatory challenges and patient connectivity.
Download this whitepaper to discover more about implementing a connected digital ecosystem, including benefits such as:
- Substantial efficiency gains
- Continued innovation in research and development
- Improved internal and external communications
Related White Papers
One of the common molecular analyses is the determination of a lead molecule’s binding kinetics and affinity to the target. This warrants the need for analytical instruments capable of characterizing such molecules. Download this whitepaper to discover an approach that accurately measures multiple high-affinity interactions over long run times.READ MORE
Data accessibility has been a challenge because the lab operator’s relationship to data is usually prescribed by preset LIMS features. Using data science algorithms, it is now possible to process and integrate all LIMS and enterprise data to provide valuable insights and timely, meaningful recommendations. Access this whitepaper to discover a technology that provides a holistic view of your data, delivers statistical and business analysis and increases productivity.
mRNA based interventions are becoming much more prevalent in current times, with several leading SARS-CoV-2 vaccines relying on mRNA technology. Access this whitepaper to learn about an affinity-based method that can streamline mRNA vaccine production and be used for biotherapeutic development.READ MORE